by Life Science Newswire | Jan 15, 2020 | Biotechnology, Drug discovery, Pharma
Sygnature Discovery has further strengthened its DMPK (drug metabolism and pharmacokinetics) capabilities, with the addition of new senior scientists to the management team. Clive Dilworth has been recruited as Director of DMPK. He replaces Tim Schulz-Utermoehl, who...
by Life Science Newswire | Jan 14, 2020 | Biomanufacturing, Bioprocessing, Biotechnology, Drug Discovery & Development, General Laboratory, Pharma
Advanced BioMatrix acquires HyStem® technology for R&D market Technology highly synergistic with existing Advanced BioMatrix products Advanced BioMatrix to fully manufacture and distribute the HyStem® kits Advanced BioMatrix has acquired the HyStem® line of...
by Life Science Newswire | Jan 13, 2020 | Biotechnology, Drug discovery, Drug Discovery & Development, General Laboratory, Microscopy & Imaging, Nanotech, Omics & Genetics, Pharma
Exosomics SpA, the leading extracellular vesicles biotech company, today announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide. In this strategic partnership, Exosomics...
by Life Science Newswire | Jan 9, 2020 | Biotechnology, Clinical diagnostics, Corporate, Finance & Investor, Drug discovery, Drug Discovery & Development, Healthcare, Pharma
Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumors for attack and destruction by the immune system Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for...
by Life Science Newswire | Jan 8, 2020 | Biotechnology, Drug Discovery & Development, Pharma
Leading in vivo pharmacology and consultancy services firm RenaSci, part of the Sygnature Group, have bolstered their Kidney Disease and Fibrosis capabilities with the appointment of Dr Wioletta Pijacka. Wioletta is an in vivo translational biologist with over 12...
